4 studies found for:
ibalizumab
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
|
||||
| 2 | Completed |
Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
|
||||
| 3 | Active, not recruiting |
Investigator-Sponsored Protocol - Continued Use of Ibalizumab
|
||||
| 4 | Unknown † |
TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1
|
† Indicates status has not been verified in more than two years